Literature DB >> 3585179

A rapid micromethod for apolipoprotein E phenotyping directly in serum.

L M Havekes, P de Knijff, U Beisiegel, J Havinga, M Smit, E Klasen.   

Abstract

A new method for the apolipoprotein E phenotyping has been developed. The method is based on isoelectric focusing of either delipidated or guanidine-HC1-treated serum or plasma in a horizontal slab gel system followed by immunoblotting using either polyclonal or monoclonal anti-apolipoprotein E antibodies as first antibody. Apolipoprotein E phenotyping with this method in 200 serum samples that had been stored at -20 degrees C for more than one year gave exactly the same results as obtained with the conventional method based on isoelectric focusing of delipidated very low density lipoproteins isolated from fresh serum followed by protein staining. Compared with the conventional method, the present method is less laborious because ultracentrifugation to isolate VLDL is not needed; it is suitable for large scale screening purposes; it needs only a few microliters of serum or plasma, and can easily be performed with samples with low concentrations of apolipoprotein E.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3585179

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  28 in total

1.  Genotypes with the apolipoprotein epsilon4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men.

Authors:  J H Stengård; J Pekkanen; C Ehnholm; A Nissinen; C F Sing
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

2.  ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment.

Authors:  Hironobu Akao; Eliana Polisecki; Ernst J Schaefer; Stella Trompet; Michele Robertson; Ian Ford; J Wouter Jukema; Anton J M de Craen; Christopher Packard; Brendan M Buckley; Kouji Kajinami
Journal:  Atherosclerosis       Date:  2014-05-08       Impact factor: 5.162

3.  Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

Authors:  N Matikainen; S Mänttäri; A Schweizer; A Ulvestad; D Mills; B E Dunning; J E Foley; M-R Taskinen
Journal:  Diabetologia       Date:  2006-07-01       Impact factor: 10.122

4.  Vitamin K Status Is not Associated with Cognitive Decline in Middle Aged Adults.

Authors:  E G H M van den Heuvel; N M van Schoor; C Vermeer; R M L Zwijsen; M den Heijer; H C Comijs
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

Review 5.  Apolipoproteins in lipid transport, an impressionist view.

Authors:  D W Erkelens
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

6.  Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels.

Authors:  M Smit; P de Knijff; M Rosseneu; J Bury; E Klasen; R Frants; L Havekes
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

7.  Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.

Authors:  A M van den Maagdenberg; W Weng; I H de Bruijn; P de Knijff; H Funke; A H Smelt; J A Gevers Leuven; F M van't Hooft; G Assmann; M H Hofker
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

8.  Apolipoprotein E genotype modifies the association between midlife lung function and cognitive function in old age.

Authors:  Erik J Giltay; Aulikki Nissinen; Simona Giampaoli; Daan Kromhout
Journal:  Dement Geriatr Cogn Disord       Date:  2009-11-10       Impact factor: 2.959

9.  Development of classification models for early identification of persons at risk for persistent cognitive decline.

Authors:  T N van den Kommer; H C Comijs; M G Dik; C Jonker; D J H Deeg
Journal:  J Neurol       Date:  2008-07-14       Impact factor: 4.849

10.  Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.

Authors:  T Demant; D Bedford; C J Packard; J Shepherd
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.